EU Firms Back MDD, Public Health Shift; Class IIb, Transparency Issues Linger
This article was originally published in The Gray Sheet
Executive Summary
European industry leaders support shifting medical device oversight within the European Commission from the directorate general for industry (DG Enterprise) to DG Sanco, the committee responsible for health and consumer protection